{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:14:46Z","timestamp":1783098886062,"version":"3.54.6"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2004,1,30]],"date-time":"2004-01-30T00:00:00Z","timestamp":1075420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Anemia is common after liver transplantation, with the incidence ranging from 4.3% to 28.2% depending on the criteria used to define anemia. The cause of anemia is unidentified in the majority of patients, and it is likely to be multifactorial. Immunosuppressive-medication-induced bone marrow suppression is perhaps the most common cause of unexplained anemia. Chronic blood loss, iron deficiency, hemolysis, and renal insufficiency are other potential causes of chronic anemia. Rare causes, somewhat unique to transplantation, include aplastic anemia, graft-versus-host disease (GVHD), and lymphoproliferative disease. Anemia due to immunosuppressive medication is challenging, since almost all drugs currently used for this purpose cause anemia, but the renal-sparing property of sirolimus may benefit the subgroup in which renal insufficiency is contributing to anemia. Aplastic anemia is seen in young patients transplanted for non-A, non-B, non-C, fulminant hepatic failure. It is thought to be immunologically mediated, secondary to an unknown viral infection, and is associated with a grave prognosis. GVHD is another infrequent (approximately 1% of transplant recipients) but serious cause of severe anemia that carries a dismal prognosis. Lymphoproliferative disorder, too may rarely rare cause anemia and it may respond to reduction of immunosuppression. Recipients of solid-organ transplants do not mount a significant increase in erythropoietin in response to anemia. In conclusion, though there are no data on the response of anemia to erythropoietin in liver transplant recipients, it appears to benefit other solid-organ-transplant recipients with anemia. (Liver Transpl 2004;10:165-173.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.20031","type":"journal-article","created":{"date-parts":[[2004,1,31]],"date-time":"2004-01-31T00:00:52Z","timestamp":1075507252000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":71,"title":["Post-liver-transplant anemia: Etiology and management"],"prefix":"10.1097","volume":"10","author":[{"given":"Anurag","family":"Maheshwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Thuluvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20250326","first-page":"289302","article-title":"Relation of disease of liver to anemia.","volume":"57","author":"Wintrobe","year":"1936","journal-title":"Arch Int Med"},{"key":"R2-1-20250326","doi-asserted-by":"crossref","first-page":"286292","DOI":"10.1172\/JCI102070","article-title":"Haematologic observations in patients with chronic hepatic insufficiency.","volume":"28","author":"Jarrold","year":"1949","journal-title":"J Clin Invest"},{"key":"R3-1-20250326","doi-asserted-by":"crossref","first-page":"332337","DOI":"10.1067\/mlc.2001.119106","article-title":"Red blood cell status in alcoholic and non-alcoholic liver disease.","volume":"138","author":"Maruyama","year":"2001","journal-title":"J Lab Clin Med"},{"key":"R4-1-20250326","doi-asserted-by":"crossref","first-page":"12511256","DOI":"10.1097\/00007890-199206000-00016","article-title":"The prevalence, course, and characteristics of chronic anemia after heart and lung transplantation.","volume":"53","author":"Hunt","year":"1992","journal-title":"Transplantation"},{"key":"R5-1-20250326","doi-asserted-by":"crossref","first-page":"15901594","DOI":"10.1097\/00007890-199712150-00015","article-title":"High prevalence of anemia after cardiac transplantation in children.","volume":"64","author":"Embleton","year":"1997","journal-title":"Transplantation"},{"key":"R6-1-20250326","doi-asserted-by":"crossref","first-page":"13061318","DOI":"10.1053\/ajkd.2002.36910","article-title":"Unexpectedly high prevalence of post-transplant anemia in pediatric and young adult renal transplant recipients.","volume":"40","author":"Yorgin","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R7-1-20250326","doi-asserted-by":"crossref","first-page":"835845","DOI":"10.1034\/j.1600-6143.2003.00133.x","article-title":"Prevalence and management of anemia in renal transplant recipients: a European survey.","volume":"3","author":"Vanrenterghem","year":"2003","journal-title":"Am J Transplant"},{"key":"R8-1-20250326","first-page":"756760","article-title":"Parvovirus B19 in anemic liver transplant recipients.","volume":"3","author":"Ndimbie","year":"1996","journal-title":"Clin Diagn Lab Immonol"},{"key":"R9-1-20250326","doi-asserted-by":"crossref","first-page":"14591463","DOI":"10.1097\/00007890-200011270-00011","article-title":"Profile of anemia in children after liver transplantation.","volume":"70","author":"Misra","year":"2000","journal-title":"Transplantation"},{"key":"R10-1-20250326","first-page":"423428","article-title":"Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection.","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"R11-1-20250326","doi-asserted-by":"crossref","first-page":"442450","DOI":"10.1053\/jlts.2001.23356","article-title":"A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.","volume":"7","author":"Wiesner","year":"2001","journal-title":"Liver Transpl"},{"key":"R12-1-20250326","doi-asserted-by":"crossref","first-page":"595597","DOI":"10.1097\/00007890-198704000-00034","article-title":"Hepatitis associated aplastic anemia after liver transplantation.","volume":"43","author":"Stock","year":"1987","journal-title":"Transplantation"},{"key":"R13-1-20250326","doi-asserted-by":"crossref","first-page":"813818","DOI":"10.1002\/hep.1840200407","article-title":"Aplastic anemia after liver transplantation for fulminant liver failure.","volume":"20","author":"Cattral","year":"1994","journal-title":"Hepatology"},{"key":"R14-1-20250326","doi-asserted-by":"crossref","first-page":"393396","DOI":"10.1056\/NEJM198808183190702","article-title":"Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis.","volume":"319","author":"Tzakis","year":"1988","journal-title":"N Eng J Med"},{"key":"R15-1-20250326","first-page":"645652","article-title":"Aplastic anemia: pathogenesis, diagnosis, treatment and prognosis.","volume":"306","author":"Camitta","year":"1982","journal-title":"N Eng J Med"},{"key":"R16-1-20250326","doi-asserted-by":"crossref","first-page":"865869","DOI":"10.1002\/hep.510260410","article-title":"Aplastic anemia complicating orthotopic liver transplantation.","volume":"26","author":"Goss","year":"1997","journal-title":"Hepatology"},{"key":"R17-1-20250326","first-page":"16611665","article-title":"Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia.","volume":"22","author":"Langnas","year":"1995","journal-title":"Hepatology"},{"key":"R18-1-20250326","doi-asserted-by":"crossref","first-page":"243247","DOI":"10.1111\/j.1399-0012.1996.tb00436.x","article-title":"Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients.","volume":"10","author":"Chang","year":"1996","journal-title":"Clin Transplant"},{"key":"R19-1-20250326","doi-asserted-by":"crossref","first-page":"695704","DOI":"10.7326\/0003-4819-109-9-695","article-title":"Epstein-Barr virus in the bone marrow of patients with aplastic anemia.","volume":"109","author":"Baranski","year":"1988","journal-title":"Ann Intern Med"},{"key":"R20-1-20250326","first-page":"3845","article-title":"The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective of marrow stromal cells.","volume":"17","author":"Apperley","year":"1989","journal-title":"Exp Hematol"},{"key":"R21-1-20250326","doi-asserted-by":"crossref","first-page":"30653068","DOI":"10.1001\/jama.1990.03440220089037","article-title":"Flaviviruses and bone marrow failure.","volume":"263","author":"Young","year":"1990","journal-title":"JAMA"},{"key":"R22-1-20250326","doi-asserted-by":"crossref","first-page":"808810","DOI":"10.1111\/j.1365-2141.1993.tb03229.x","article-title":"Lack of evidence for a role of HCV in hepatitis-associated aplastic anemia.","volume":"85","author":"Pol","year":"1993","journal-title":"Br J Haematol"},{"key":"R23-1-20250326","doi-asserted-by":"crossref","first-page":"755759","DOI":"10.1002\/hep.1840080409","article-title":"In vitro hepatitis B virus suppression of erythropoiesis is dependent on the multiplicity of infection and is reversible with anti-HBs antibodies.","volume":"8","author":"Zeldis","year":"1988","journal-title":"Hepatology"},{"key":"R24-1-20250326","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1016\/0002-9343(83)91119-1","article-title":"Aplastic anemia and non-A, non-B hepatitis.","volume":"74","author":"Zeldis","year":"1983","journal-title":"Am J Med"},{"key":"R25-1-20250326","doi-asserted-by":"crossref","first-page":"15571558","DOI":"10.1001\/archinte.1978.03630350081022","article-title":"Aplastic anemia associated with type B viral hepatitis.","volume":"138","author":"Casciato","year":"1978","journal-title":"Arch Intern Med"},{"key":"R26-1-20250326","doi-asserted-by":"crossref","first-page":"952955","DOI":"10.1016\/0140-6736(92)91530-L","article-title":"Hepatitis B virus and apparent fulminant non-A, non-B hepatitis.","volume":"339","author":"Wright","year":"1992","journal-title":"Lancet"},{"key":"R27-1-20250326","first-page":"117123","article-title":"Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of literature.","volume":"15","author":"Itterbeek","year":"2002","journal-title":"Transpl Int"},{"key":"R28-1-20250326","first-page":"11101115","article-title":"A comparison of Tacrolimus (FK506) and Cyclosporine for immunosuppression in liver transplantation.","volume":"331","year":"1994","journal-title":"N Eng J Med"},{"key":"R29-1-20250326","first-page":"13211325","article-title":"Placebo-controlled study of mycophenolate mofetil combined with Cyclosporine and corticosteroids for prevention of acute rejection.","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"R30-1-20250326","doi-asserted-by":"crossref","first-page":"262265","DOI":"10.1034\/j.1399-0012.2000.140314.x","article-title":"Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.","volume":"14","author":"Rerolle","year":"2000","journal-title":"Clin Transplant"},{"key":"R31-1-20250326","doi-asserted-by":"crossref","first-page":"310312","DOI":"10.1002\/(SICI)1096-8652(199608)52:4<310::AID-AJH11>3.0.CO;2-H","article-title":"Microangiopathic hemolytic anemia complicating FK506 (Tacrolimus) therapy.","volume":"52","author":"Mach-Pascual","year":"1996","journal-title":"Am J Hematol"},{"key":"R32-1-20250326","first-page":"322324","article-title":"Microangiopathic hemolytic anemia secondary to cyclosporine therapy in a heart and lung transplant recipient.","volume":"15","author":"Oteo","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"R33-1-20250326","doi-asserted-by":"crossref","first-page":"575577","DOI":"10.1097\/00007890-199802270-00021","article-title":"Red cell aplasia in children in tacrolimus after liver transplantation.","volume":"65","author":"Misra","year":"1998","journal-title":"Transplantation"},{"key":"R34-1-20250326","doi-asserted-by":"crossref","first-page":"118126","DOI":"10.1097\/00007890-200301150-00022","article-title":"Liver transplant-associated graft-versus-host disease.","volume":"75","author":"Smith","year":"2003","journal-title":"Transplantation"},{"key":"R35-1-20250326","doi-asserted-by":"crossref","first-page":"262269","DOI":"10.1097\/00007890-198802000-00002","article-title":"Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum.","volume":"45","author":"Shaffer","year":"1988","journal-title":"Transplantation"},{"key":"R36-1-20250326","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1046\/j.1537-2995.1991.31191096190.x","article-title":"Red cell antibodies arising from solid organ transplants.","volume":"31","author":"Ramsey","year":"1991","journal-title":"Transfusion"},{"key":"R37-1-20250326","doi-asserted-by":"crossref","first-page":"180183","DOI":"10.1097\/00000658-198908000-00007","article-title":"Reversal of hypersplenism following orthotopic liver transplantation.","volume":"210","author":"Yanaga","year":"1989","journal-title":"Ann Surg"},{"key":"R38-1-20250326","first-page":"1987","article-title":"Impact of liver transplantation on the reversal of hypersplenism.","volume":"25","author":"Witte","year":"1993","journal-title":"Transpl Proc"},{"key":"R39-1-20250326","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1097\/00004836-200307000-00018","article-title":"Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy.","volume":"37","author":"Atassi","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"R40-1-20250326","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0016-5085(03)83731-9","article-title":"Anemia is associated with renal dysfunction in patients with cirrhosis. Abstract.","volume":"124","author":"Patt","year":"2003","journal-title":"Gastroenterology"},{"key":"R41-1-20250326","doi-asserted-by":"crossref","first-page":"912922","DOI":"10.1053\/jlts.2002.35668","article-title":"Chronic renal dysfunction late after liver transplantation.","volume":"8","author":"Cohen","year":"2002","journal-title":"Liver Transpl"},{"key":"R42-1-20250326","doi-asserted-by":"crossref","first-page":"741747","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients.","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"key":"R43-1-20250326","doi-asserted-by":"crossref","first-page":"19341939","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy.","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"key":"R44-1-20250326","doi-asserted-by":"crossref","first-page":"265276","DOI":"10.1093\/ajcp\/99.3.265","article-title":"Posttransplantation lymphoproliferative disorders.","volume":"99","author":"Craig","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"R45-1-20250326","doi-asserted-by":"crossref","first-page":"15664","DOI":"10.1055\/s-2007-1007272","article-title":"Malignancies after liver transplantation: a comparative review.","volume":"15","author":"Tan-Shalaby","year":"1995","journal-title":"Semin Liver Dis"},{"key":"R46-1-20250326","first-page":"282285","article-title":"Tacrolimus-related post transplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia.","volume":"120","author":"DiGiuseppe","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"R47-1-20250326","doi-asserted-by":"crossref","first-page":"349355","DOI":"10.1053\/lv.2000.6140","article-title":"Erythopoietin response to post-liver transplantation anemia.","volume":"6","author":"Vasilopoulos","year":"2000","journal-title":"Liver Transpl"},{"key":"R48-1-20250326","doi-asserted-by":"crossref","first-page":"12451251","DOI":"10.1097\/00007890-199512000-00012","article-title":"Anemia and erythropoietin levels in lung transplant recipients.","volume":"60","author":"End","year":"1995","journal-title":"Transplantation"},{"key":"R49-1-20250326","first-page":"10081011","article-title":"Anemia and erythropoietin levels in recipients of solid organ transplants.","volume":"56","author":"Frost","year":"1993","journal-title":"Transplantation"},{"key":"R50-1-20250326","doi-asserted-by":"crossref","first-page":"113118","DOI":"10.1056\/NEJM198301203080301","article-title":"Antithymocyte globulin treatment in patients with aplastic anemia.","volume":"308","author":"Champlin","year":"1983","journal-title":"N Engl J Med"},{"key":"R51-1-20250326","doi-asserted-by":"crossref","first-page":"523526","DOI":"10.1038\/sj.bmt.1703177","article-title":"Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long term follow up and outcome.","volume":"28","author":"Perkins","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R52-1-20250326","first-page":"12071208","article-title":"Successful allogenic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis.","volume":"64","author":"Hagglund","year":"1997","journal-title":"Transplantation"},{"key":"R53-1-20250326","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1111\/j.1432-2277.2002.tb00096.x","article-title":"Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance.","volume":"15","author":"Stachel","year":"2002","journal-title":"Transpl Int"},{"key":"R54-1-20250326","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1111\/j.1432-2277.1996.tb00855.x","article-title":"Hemolytic uremic syndrome in solid organ transplant recipients.","volume":"9","author":"Singh","year":"1996","journal-title":"Transpl Int"},{"key":"R55-1-20250326","first-page":"527528","article-title":"Evans syndrome complicating chronic graft versus host disease after cadaveric liver transplantation.","volume":"72","author":"Au","year":"2001","journal-title":"Transplantation"},{"key":"R56-1-20250326","doi-asserted-by":"crossref","first-page":"307310","DOI":"10.1097\/00007890-200201270-00030","article-title":"Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression.","volume":"73","author":"Lehner","year":"2002","journal-title":"Transplantation"},{"key":"R57-1-20250326","doi-asserted-by":"crossref","first-page":"10241029","DOI":"10.1034\/j.1600-6143.2003.00108.x","article-title":"Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection.","volume":"3","author":"Sudhindran","year":"2003","journal-title":"Am J Transplant"},{"key":"R58-1-20250326","doi-asserted-by":"crossref","first-page":"364370","DOI":"10.1097\/01.TP.0000074360.62032.39","article-title":"Rapamune Maintenance Regimen Study Group. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.","volume":"76","author":"Oberbauer","year":"2003","journal-title":"Transplantation"},{"key":"R59-1-20250326","doi-asserted-by":"crossref","first-page":"126129","DOI":"10.1053\/jlts.2003.50026","article-title":"Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients.","volume":"9","author":"Nair","year":"2003","journal-title":"Liver Transpl"},{"key":"R60-1-20250326","doi-asserted-by":"crossref","first-page":"10791085","DOI":"10.1053\/jlts.2003.50183","article-title":"Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.","volume":"9","author":"Fairbanks","year":"2003","journal-title":"Liver Transpl"},{"key":"R61-1-20250326","doi-asserted-by":"crossref","first-page":"18151821","DOI":"10.1093\/oxfordjournals.ndt.a027674","article-title":"Recombinant human erythropoietin corrects anemia during the first weeks after renal transplantation: a randomized prospective study.","volume":"11","author":"Van Loo","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R62-1-20250326","first-page":"S8692","article-title":"Erythropoietin and renal transplantation.","volume":"69","author":"Muirhead","year":"1999","journal-title":"Kidney Int Suppl"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20031","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20031","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200402000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T09:53:29Z","timestamp":1743242009000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200402000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20031","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}